首页> 中文期刊> 《中国肿瘤临床》 >金龙胶囊抗脑肿瘤的系统生物学研究

金龙胶囊抗脑肿瘤的系统生物学研究

         

摘要

This article focuses on the research of molecular mechanism of brain tumor treatment using the Jinlong capsule via system biology technology. Methods:Human Genome U133 Plus 2.0 gene chip was used to detect the genes of samples, in-cluding the brain tumor tissues of nude mice after Jinlong capsule intervention and those of blank control group mice. Differentially ex-pressed genes were identified based on fold change between the two groups. To identify the upstream regulators of the response signa-tures, the differentially expressed genes were subjected to interactome analysis by one-step overconnectivity test and multi-step hidden node algorithm. A set of genes preferentially connected to differentially expressed genes via direct interactions and pathways (called to-pologically significant genes) was generated. Concurrent pathway enrichment analysis on key pathways, processes, and functional units of both differentially expressed genes and topologically significant genes was performed to identify the most likely signaling pathways connecting regulators and effector genes. Finally, condition-specific networks (called causal network) were built to model molecular events by using a set of manually annotated protein interactions, pathways, and proteins and a toolkit of algorithms and filters on Meta-Core platform. Results:A total of 37 differentially expressed genes have been identified between Jinlong capsule-treated sample and ve-hicle sample with fold change of 2. Connection analysis identified 106 topologically significant genes. The main feature of the causal network is stimulation of neural cell specific genes that regulate normal cell physiology, particularly developmental processes and apop-tosis. Another important effect of the Jinlong capsule is its inhibition of the gene markers of interferon response, suggesting signaling in-hibition, followed by de-activation of immune response. Conclusion:Jinlong capsule exerts an anti-neoplastic effect by inducing stimu-lation of neural cell and by inhibiting interferon signal transduction.%目的:利用系统生物学技术分析中药复方金龙胶囊抗脑肿瘤的分子机制。方法:取金龙胶囊组及空白对照组小鼠的原位脑肿瘤组织样本进行基因芯片检测,通过比对获取差异基因;使用一步过连通测算和多步骤隐藏节点测算获得拓扑基因;采用富集分析法分析其生物功能;借助MetaCore平台构建分子机制网络图。结果:与对照组相比,金龙胶囊组共有37个差异基因(倍数>2),106个拓扑基因。金龙胶囊的靶点主要集中在细胞粘附和凋亡、免疫应答、神经组织发育等。结论:金龙胶囊通过诱导神经细胞特有基因表达和抑制干扰素信号转导发挥抗脑肿瘤作用。

著录项

  • 来源
    《中国肿瘤临床》 |2014年第13期|856-860|共5页
  • 作者单位

    北京鲜动物药研制中心 北京市100039;

    北京建生药业有限公司;

    北京鲜动物药研制中心 北京市100039;

    北京建生药业有限公司;

    北京鲜动物药研制中心 北京市100039;

    北京建生药业有限公司;

    北京鲜动物药研制中心 北京市100039;

    北京建生药业有限公司;

    北京鲜动物药研制中心 北京市100039;

    北京建生药业有限公司;

    北京鲜动物药研制中心 北京市100039;

    北京建生药业有限公司;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

    金龙胶囊; 基因芯片; 系统生物学; 脑肿瘤; 机制;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号